PediaMetrix Receives $2 Million NIH Grant to Expand Pediatric AI Diagnostic Tools

The National Institutes of Health has awarded PediaMetrix, Inc. a $2 million grant through its Commercialization Readiness Program to accelerate the development and commercialization of pediatric AI health solutions. This funding will support the expansion of the company's SoftSpot Total Care Solution, which includes enhanced 2D and 3D imaging capabilities for cranial shape screening.

The NIH CRP funding serves a later-stage mission designed to bridge the gap between development and full-scale commercialization for promising biomedical technologies. This award will enable PediaMetrix to prepare its AI tools for broader clinical and commercial adoption, positioning the technology for wider implementation in pediatric care settings. The grant represents a significant validation of the company's approach to addressing critical pediatric health needs through artificial intelligence and computer vision technologies.

SoftSpot, as the first FDA-cleared mobile app of its kind, has already empowered pediatricians and parents to scan infants' heads quickly and efficiently for cranial shape abnormalities. With this new funding, the expanded SoftSpot Total Care Solution will deliver richer diagnostic insights through refined imaging capabilities. The company is extending its reach beyond cranial analysis by developing complementary AI solutions such as EarSpot for early ear deformity screening and upcoming tools for detecting dental and other pediatric abnormalities.

This commercialization readiness funding will support the advancement of next-generation AI tools that could significantly improve early detection of various pediatric conditions. The development of these innovative diagnostic tools aligns with PediaMetrix's mission to enhance early detection capabilities while reducing the overall cost of pediatric care through technological innovation.